NCT04523688
Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate in Glioblastoma treatment 2 recruiting NCT04559230
Sacituzumab Govitecan in Recurrent Glioblastoma treatment 2 recruiting NCT04566393
Expanded Access to Ulixertinib (BVD-523) in Patients with Advanced MAPK Pathway-Altered Malignancies Not Available Not Available available NCT04699773
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138) No drug interventions treatment Not Available recruiting NCT04730869
Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma No drug interventions treatment Not Available active_not_recruiting NCT04817254
Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma treatment 2 recruiting NCT05099003
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG) treatment 1 / 2 recruiting NCT05187624
A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma No drug interventions treatment 1 recruiting NCT05271240
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM treatment 3 recruiting NCT05342883
GammaTile and Stupp in Newly Diagnosed GBM No drug interventions treatment 4 recruiting NCT05607407
Methimazole in Patients With Progressive Glioblastoma treatment 2 recruiting NCT05773664
Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma treatment 1 withdrawn NCT05839379
Targeted Pediatric High-Grade Glioma Therapy No drug interventions Not Available Not Available recruiting NCT05843253
Study of Ribociclib and Everolimus in HGG and DIPG treatment 2 recruiting NCT05900908
Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy No drug interventions treatment 4 not_yet_recruiting NCT05902169
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM treatment 3 recruiting NCT05954858
Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma No drug interventions treatment Not Available recruiting NCT05979064
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM) No drug interventions treatment Not Available recruiting NCT06061809
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma treatment 2 recruiting NCT06404034
Expanded Access to Gallium Maltolate (GaM) Not Available Not Available available NCT06613841
Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma No drug interventions diagnostic 0 not_yet_recruiting NCT06614855
A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma No drug interventions treatment 1 not_yet_recruiting NCT06600399
Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma No drug interventions Not Available Not Available completed NCT02871843
RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic Gliomas treatment 1 completed NCT03223103
Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma treatment 1 active_not_recruiting NCT06090903
Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma No drug interventions screening Not Available recruiting NCT04221503
Niraparib/TTFields in GBM treatment 2 active_not_recruiting NCT02599090
Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma treatment 2 withdrawn NCT01609790
Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors treatment 2 completed NCT04209790
Neoadjuvant Chemoradiation for Resectable Glioblastoma treatment 2 recruiting NCT02942264
Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma treatment 1 / 2 completed NCT04047264
Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies No drug interventions basic_science Not Available recruiting NCT05664464
Glutamate Inhibitors in Glioblastoma treatment 1 / 2 recruiting NCT05326464
Tofacitinib in Recurrent GBM Patients treatment 3 recruiting NCT04998864
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients No drug interventions Not Available Not Available unknown_status NCT02478164
Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma treatment 2 completed NCT05871021
Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma No drug interventions treatment 2 recruiting NCT06480721
FET-PET-Guided Management of Pseudoprogression in Glioblastoma No drug interventions diagnostic Not Available not_yet_recruiting NCT00689221
Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status treatment 3 completed NCT00100802
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas treatment 2 completed NCT05629702
ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids treatment 2 recruiting NCT01434602
Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas treatment 1 / 2 completed NCT03213002
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM treatment 1 / 2 recruiting NCT05140902
Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom No drug interventions diagnostic Not Available active_not_recruiting NCT04741984
Monocyte Antigen Carrier Cells for Newly Diagnosed GBM treatment 1 withdrawn NCT01156584
A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma treatment 1 completed NCT02473484
Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas No drug interventions Not Available Not Available completed NCT02725684
Using Genomic Analysis to Guide Individual Treatment in Glioblastoma No drug interventions Not Available Not Available completed NCT03452579
Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM treatment 2 active_not_recruiting NCT04397679
Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma treatment 1 active_not_recruiting NCT04478279
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT03603379
Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas No drug interventions basic_science 1 completed NCT02342379
TH-302 in Combination With Bevacizumab for Glioblastoma treatment 2 completed NCT00813943
Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status treatment 2 completed NCT00575887
Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma treatment 2 completed NCT05768087
Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients No drug interventions treatment Not Available recruiting NCT02648633
Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma treatment 1 terminated NCT01851733
MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme treatment 1 completed NCT04417933
Tumor Electric Fields Treatment System for Glioblastoma No drug interventions device_feasibility 0 unknown_status NCT03463733
Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma) treatment 1 unknown_status NCT00613054
Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma treatment 1 completed NCT00080054
A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas treatment 1 completed NCT02254954
Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma treatment 1 terminated NCT01817751
Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma treatment 2 completed NCT03705351
Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM treatment 1 terminated NCT00087451
Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED) treatment 1 completed NCT00612651
PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas treatment 1 completed NCT04474353
Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma treatment 1 active_not_recruiting NCT00115453
Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma No drug interventions treatment 1 / 2 terminated NCT00165477
Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme treatment 2 completed NCT04552977
A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma treatment 2 unknown_status NCT01721577
Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas treatment 1 / 2 terminated NCT04555577
Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma treatment 1 recruiting NCT03636477
A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102 treatment 1 completed NCT02410577
89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme No drug interventions diagnostic Not Available completed NCT01813877
Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma No drug interventions diagnostic Not Available completed NCT04545177
Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue No drug interventions device_feasibility Not Available active_not_recruiting NCT01100177
Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients treatment 2 completed NCT04801147
Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme treatment 1 / 2 unknown_status NCT04599647
EAP for the Treatment of Glioblastoma With PVSRIPO Not Available Not Available no_longer_available NCT02866747
A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma treatment 1 / 2 active_not_recruiting NCT01465347
Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma treatment 1 / 2 completed NCT03392545
Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1) No drug interventions treatment 1 unknown_status NCT05917145
Clinical Trial of the ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Recurrent Brain Tumors No drug interventions treatment 1 recruiting NCT04359745
Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression No drug interventions Not Available Not Available recruiting NCT02457845
HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors treatment 1 completed NCT01931098
Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab treatment 2 completed NCT00616005
Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide treatment 2 completed NCT04243005
Supramarginal Resection in Glioblastoma No drug interventions treatment Not Available recruiting NCT06113705
Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study. No drug interventions diagnostic Not Available not_yet_recruiting NCT01516905
PET/CT Imaging of Malignant Brain Tumors With 124I-NM404 No drug interventions Not Available Not Available completed NCT02590497
Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery diagnostic Not Available withdrawn NCT01598597
An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite) No drug interventions Not Available Not Available completed NCT01111097
Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors treatment 1 completed NCT02715297
Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma No drug interventions treatment 2 unknown_status NCT04829097
Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma treatment 3 unknown_status NCT02359097
Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma diagnostic Not Available completed NCT00238797
A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme treatment 2 completed NCT03491683
INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM) treatment 1 / 2 active_not_recruiting NCT03877861
Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms No drug interventions Not Available Not Available completed NCT00200161
Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma treatment 2 completed NCT00431561
Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma treatment 2 completed NCT01632228
A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma treatment 2 completed NCT02466828
qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia. diagnostic 0 completed NCT00624728
Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP) No drug interventions diagnostic 1 / 2 completed NCT02287428
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM treatment 1 recruiting NCT01905228
A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm No drug interventions treatment 1 completed NCT06512311
Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening No drug interventions other Not Available recruiting NCT01535911
Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors No drug interventions treatment Not Available active_not_recruiting NCT00250211
Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide No drug interventions treatment 1 / 2 completed NCT01491893
PVSRIPO for Recurrent Glioblastoma (GBM) treatment 1 completed NCT00906893
Evaluation of [18F]-FMISO for Non Operated Glioblastoma No drug interventions health_services_research 2 completed NCT03593993
A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas No drug interventions Not Available Not Available terminated NCT06496971
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients treatment 3 not_yet_recruiting NCT01846871
Tivozanib for Recurrent Glioblastoma treatment 2 completed NCT03548571
Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy treatment 2 / 3 recruiting NCT05735171
Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence No drug interventions treatment Not Available recruiting NCT01478178
Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma treatment 1 / 2 completed NCT02743078
Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma treatment 2 terminated NCT03688178
DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab treatment 2 active_not_recruiting NCT05439278
Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma treatment 3 not_yet_recruiting NCT02770378
A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma treatment 1 / 2 completed NCT06058988
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer treatment 2 recruiting NCT03137888
Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma treatment 2 active_not_recruiting NCT03293888
Spectral Analysis Probe to Identify Glioblastoma Cells No drug interventions Not Available Not Available terminated NCT01105988
Evaluating Tumor Pseudoprogression With FLT-PET and MRI No drug interventions diagnostic 0 terminated NCT03926507
F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery No drug interventions diagnostic Not Available completed NCT04135807
Implantable Microdevice In Primary Brain Tumors No drug interventions diagnostic 0 recruiting NCT06551909
Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2) No drug interventions treatment Not Available not_yet_recruiting NCT04614909
Study of Pamiparib in Newly Diagnosed and rGBM treatment 0 recruiting NCT03787056
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients No drug interventions diagnostic Not Available recruiting NCT04574856
Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma treatment 2 recruiting NCT01957956
Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma treatment 0 completed NCT01403285
Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma treatment 1 terminated NCT05756985
Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue No drug interventions Not Available Not Available not_yet_recruiting NCT00295815
Enzastaurin Versus Lomustine in Glioblastoma treatment 3 completed NCT04657315
Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients No drug interventions treatment 1 / 2 completed NCT05131815
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors No drug interventions supportive_care Not Available active_not_recruiting NCT02893137
Enhancing Optune Therapy With Targeted Craniectomy No drug interventions treatment 1 completed NCT02841332
Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma basic_science Not Available terminated NCT06385132
Psychological and Psychiatric prOfile in Glioblastoma and Head and Neck Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT02919332
Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma No drug interventions Not Available Not Available withdrawn NCT03732352
18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients With EGFR Activated Recurrent Glioblastoma treatment 2 active_not_recruiting NCT00068952
Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme treatment 3 completed NCT03233152
Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent Glioblastoma treatment 1 unknown_status NCT04959500
Newly Diagnosed Glioblastoma treatment 2 unknown_status NCT05054400
Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR treatment 0 withdrawn NCT00088400
Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors treatment 3 completed NCT00335075
Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644) treatment 3 completed NCT04219475
Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients No drug interventions Not Available Not Available suspended NCT04469075
Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields treatment 2 recruiting NCT02678975
Disulfiram in Recurrent Glioblastoma treatment 2 / 3 completed NCT06329570
Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM) treatment 1 / 2 not_yet_recruiting NCT00671970
Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG) treatment 2 completed NCT01520870
Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT. treatment 2 completed NCT04313842
A Explorative Study to Evaluate the Clinical Feasibility of AVATAMED No drug interventions Not Available Not Available unknown_status NCT03951142
Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study diagnostic 2 enrolling_by_invitation NCT03869242
NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM No drug interventions treatment Not Available unknown_status NCT03250299
Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma treatment 1 terminated NCT04716699
Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma basic_science 1 completed NCT01854099
Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens treatment 1 withdrawn NCT03861299
The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients. No drug interventions treatment Not Available recruiting NCT04047706
Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma treatment 1 active_not_recruiting NCT02343406
Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas treatment 2 completed NCT04874506
MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM) treatment 2 unknown_status NCT03341806
Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma treatment 1 completed NCT01507506
Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma No drug interventions treatment 3 terminated NCT02010606
Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma treatment 1 completed NCT03197506
Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma treatment 2 suspended NCT03278249
Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma No drug interventions treatment Not Available unknown_status NCT03980249
Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells treatment 0 withdrawn NCT04485949
A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma treatment 2 active_not_recruiting NCT05236036
Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma treatment 1 recruiting NCT03050736
Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression treatment 2 active_not_recruiting NCT00354913
Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma treatment 2 completed NCT03734913
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT01189513
SCH-900105 in Recurrent Glioblastoma No drug interventions treatment 1 withdrawn NCT03246113
Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma treatment 1 terminated NCT03477513
Personalized Radiation Therapy for GBM No drug interventions treatment Not Available active_not_recruiting NCT06418113
Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma No drug interventions treatment 1 recruiting NCT05551013
Treatment of Recurrent GBM With APG-157 Via Expanded Access Not Available Not Available no_longer_available NCT04937413
The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation basic_science 0 completed NCT05375318
BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels No drug interventions Not Available Not Available unknown_status NCT05565118
Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression No drug interventions treatment 1 recruiting NCT01351519
A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors treatment 2 terminated NCT00780819
Borderzone Sampling No drug interventions diagnostic Not Available completed NCT01083719
A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes. No drug interventions treatment 2 unknown_status NCT06105619
A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN). treatment 2 / 3 active_not_recruiting NCT02585219
Pilot Viability of 11C-MET-PET as a Post-surgery Baseline Scan in High-grade Gliomas No drug interventions Not Available Not Available unknown_status NCT01493219
Biomarkers for Prognosis of Glioblastoma (GBM) No drug interventions Not Available Not Available completed NCT05095441
A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma No drug interventions treatment 1 not_yet_recruiting NCT05772741
Grafts of GSCs Into Brain Organoids for Testing Anti-invasion Drugs No drug interventions basic_science Not Available recruiting NCT01502241
Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly treatment 3 completed NCT02432417
The Addition of Chloroquine to Chemoradiation for Glioblastoma, treatment 2 withdrawn NCT05635734
Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma treatment 1 / 2 recruiting NCT01653834
Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas No drug interventions treatment Not Available completed NCT02611024
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors treatment 1 / 2 recruiting NCT02345824
Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma treatment 1 unknown_status NCT01421524
Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma treatment 1 completed NCT00402116
Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients treatment 1 / 2 completed NCT01975116
p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors treatment 1 completed NCT04446416
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients treatment Not Available completed NCT00884416
Sorafenib in Newly Diagnosed High Grade Glioma treatment 1 completed NCT04868396
Patient-derived Glioma Stem Cell Organoids No drug interventions Not Available Not Available active_not_recruiting NCT02238496
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas treatment 1 completed NCT05106296
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer treatment 1 recruiting NCT04479696
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors No drug interventions supportive_care Not Available recruiting NCT01454596
CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII treatment 1 / 2 completed NCT00132158
ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors treatment 1 completed NCT04604158
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients No drug interventions supportive_care Not Available completed NCT02047058
Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics No drug interventions Not Available Not Available unknown_status NCT02684058
Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors treatment 2 completed NCT03939858
Bioenergetic Profiling and Cognition in GBM Patients No drug interventions Not Available Not Available terminated NCT01383135
Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2 No drug interventions diagnostic 0 completed NCT02520635
Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients Not Available Not Available unknown_status NCT02129335
Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner No drug interventions Not Available Not Available terminated NCT02899663
MRI Detection of Microbleeds in Glioma Patients No drug interventions Not Available Not Available completed NCT00345163
A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN) treatment 2 completed NCT03287063
Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma No drug interventions Not Available Not Available suspended NCT06556563
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma treatment 3 not_yet_recruiting NCT05304663
Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First Progression treatment 1 withdrawn NCT06524063
Targeted Survivin DC Cell Injection for the Treatment of GBM No drug interventions treatment 1 not_yet_recruiting NCT02664363
EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma No drug interventions treatment 1 terminated NCT02800486
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA treatment 2 recruiting NCT03506139
Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma No drug interventions treatment 2 withdrawn NCT04225039
Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma treatment 2 active_not_recruiting NCT00612339
Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas treatment 2 completed NCT06477939
Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients treatment 3 not_yet_recruiting NCT05296122
Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions No drug interventions device_feasibility Not Available active_not_recruiting NCT03927222
Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma treatment 2 terminated NCT00365222
Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma treatment 2 terminated NCT00525525
Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma treatment 2 completed NCT04541225
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors No drug interventions treatment 1 terminated NCT03297125
Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI No drug interventions Not Available Not Available recruiting NCT02149225
GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients treatment 1 completed NCT00643825
Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients treatment 2 unknown_status NCT00611325
Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma treatment 2 completed NCT01044225
Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma treatment 2 terminated NCT02904525
Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model No drug interventions diagnostic Not Available unknown_status NCT06102525
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma treatment 1 / 2 recruiting NCT02490930
A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma other 0 completed NCT01903330
ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme treatment 2 unknown_status NCT05353530
Phase I Study of IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma (IMPACT) No drug interventions treatment 1 recruiting NCT02206230
Trial of Hypofractionated Radiation Therapy for Glioblastoma No drug interventions treatment 2 completed NCT03452930
Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma treatment 1 completed NCT03389230
Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma No drug interventions treatment 1 active_not_recruiting NCT05463848
Surgical Pembro +/- Olaparib w TMZ for rGBM treatment 2 recruiting NCT04280848
Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma treatment 2 active_not_recruiting NCT00392548
URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol No drug interventions Not Available Not Available unknown_status NCT02902757
FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma No drug interventions diagnostic Not Available recruiting NCT00973557
The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function No drug interventions Not Available Not Available completed NCT02629757
A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas No drug interventions treatment 3 unknown_status NCT03797326
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) treatment 2 active_not_recruiting NCT02394626
Surgery for Recurrent Glioblastoma No drug interventions treatment 2 recruiting NCT02666066
Radiomics for Prediction of Survival in GBM No drug interventions Not Available Not Available completed NCT04732065
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors treatment 1 recruiting NCT02394665
Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma treatment 2 terminated NCT03452774
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry No drug interventions Not Available Not Available recruiting NCT04105374
Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma treatment 2 / 3 withdrawn NCT04119674
Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma treatment 1 / 2 completed NCT01522820
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors treatment 1 completed NCT04583020
Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma treatment 2 unknown_status NCT02176720
Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma No drug interventions diagnostic 1 terminated NCT01291420
Dendritic Cell Vaccination for Patients With Solid Tumors No drug interventions treatment 1 / 2 completed NCT06439420
CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial No drug interventions treatment 2 recruiting NCT02152982
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme treatment 2 / 3 active_not_recruiting NCT01380782
BIBF 1120 for Recurrent High-Grade Gliomas treatment 2 completed NCT05063682
The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients No drug interventions treatment 1 unknown_status NCT02025231
Image Guided Reirradiation of High-grade Glioma No drug interventions treatment 1 / 2 terminated NCT03481231
In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With Glioblastoma No drug interventions Not Available Not Available active_not_recruiting NCT04623931
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas treatment 2 recruiting NCT01011231
Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma No drug interventions treatment 2 terminated NCT03539731
[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers No drug interventions diagnostic 1 terminated NCT01898273
Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma diagnostic 2 terminated NCT03251027
Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma No drug interventions treatment Not Available recruiting NCT06283927
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302) Not Available Not Available recruiting NCT01112527
PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma treatment 2 completed NCT00807027
Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea No drug interventions treatment 3 completed NCT00723827
Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2) Not Available Not Available completed NCT01443676
Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma treatment 2 completed NCT01782976
Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM) treatment 2 withdrawn NCT05695976
GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM No drug interventions Not Available Not Available recruiting NCT04319276
Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma treatment 1 recruiting NCT05095376
Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma treatment 3 recruiting NCT01954576
NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme No drug interventions treatment Not Available terminated NCT06129760
Glioblastoma Remote Monitoring and Care - Research Protocol No drug interventions treatment Not Available recruiting NCT03616860
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma No drug interventions treatment Not Available completed NCT01240460
Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection treatment 1 completed NCT00895960
Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma treatment 1 terminated NCT03176160
LITT Palliative Treatment for Patients With Malignant Gliomas No drug interventions Not Available Not Available withdrawn NCT03778294
18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy treatment 2 completed NCT03422094
Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma treatment 1 terminated NCT00667394
Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors treatment 2 completed NCT01095094
Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma treatment 2 terminated NCT01331291
Bosutinib in Adult Patients With Recurrent Glioblastoma treatment 2 completed NCT01445691
More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery treatment 2 withdrawn NCT02644291
Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors treatment 1 completed NCT05600491
A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme treatment 3 recruiting NCT06336291
A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence treatment 2 not_yet_recruiting NCT02330991
A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse treatment 2 completed NCT05502991
Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma treatment 2 not_yet_recruiting NCT00939991
Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas treatment 1 / 2 completed NCT01752491
A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme treatment 1 active_not_recruiting NCT03897491
PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma treatment 2 recruiting NCT03743662
Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma treatment 2 active_not_recruiting NCT02717962
Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting treatment 2 active_not_recruiting NCT03434262
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors treatment 1 completed NCT04391062
Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma treatment 2 recruiting NCT04019262
Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma treatment 1 / 2 active_not_recruiting NCT02754362
A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma treatment 2 withdrawn NCT04752280
Glioblastoma Radiotherapy Using IMRT or Proton Beams No drug interventions treatment Not Available recruiting NCT03107780
Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer treatment 1 suspended NCT01656980
Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma treatment 3 unknown_status NCT02698280
Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma treatment 2 completed NCT00821080
Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma treatment 1 completed NCT00761280
Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma treatment 3 terminated NCT02709889
Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors treatment 1 / 2 terminated NCT02768389
Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma treatment 0 completed NCT06455189
Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas No drug interventions treatment 1 not_yet_recruiting NCT05590689
Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor treatment 1 / 2 recruiting NCT05074992
A Trial of Neoadjuvant Therapy in Patients With Newly Diagnosed Glioblastoma treatment 2 terminated NCT03581292
Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations treatment 2 active_not_recruiting NCT01702792
Derivation of Tumor Specific Hybridomas treatment 1 terminated NCT04900792
A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma treatment 1 recruiting NCT03405792
Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP) treatment 2 active_not_recruiting NCT05450744
131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) treatment 1 recruiting NCT04734444
SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue No drug interventions other Not Available recruiting NCT02283944
TMS Electrochemotherapy for Glioblastoma Multiforme No drug interventions treatment 2 withdrawn NCT02968940
Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma treatment 2 completed NCT03048240
INtraoperative photoDYnamic Therapy of GliOblastoma treatment Not Available completed NCT04324840
A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma treatment 1 terminated NCT03144167
Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy No drug interventions other Not Available unknown_status NCT00921167
A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas treatment 2 completed NCT00684567
Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED) treatment 2 completed NCT01260467
Memantine for Recurrent Glioblastoma treatment 2 terminated NCT01473901
A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma treatment 1 completed NCT00944801
Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma treatment 1 / 2 completed NCT05410301
Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma treatment Not Available withdrawn NCT06186401
Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells treatment 1 recruiting NCT02833701
Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma treatment 1 terminated NCT01514201
Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas treatment 1 / 2 completed NCT04002804
Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Recurrence Of Glioblastoma Multiforme treatment 1 terminated NCT03224104
Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma treatment 1 completed NCT03615404
Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma treatment 1 completed NCT02085304
Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM treatment 1 / 2 terminated NCT06038604
Glioblastoma Psychosocial Support Program No drug interventions supportive_care Not Available completed NCT03739372
Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma No drug interventions treatment Not Available active_not_recruiting NCT05062772
Brain Tumor Intraoperative Ultrasound Database No drug interventions Not Available Not Available recruiting NCT05383872
Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors No drug interventions diagnostic Not Available recruiting NCT03770468
Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma No drug interventions Not Available Not Available completed NCT01310868
Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma treatment 2 completed NCT00045968
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer treatment 3 unknown_status NCT01171469
Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor treatment 1 completed NCT04049669
Pediatric Trial of Indoximod with Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG treatment 2 recruiting NCT02903069
Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer treatment 1 completed NCT01259869
A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression treatment 2 completed NCT03390569
Exercise in Patients With Glioblastoma No drug interventions supportive_care Not Available completed NCT03514069
Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma treatment 1 active_not_recruiting NCT01067469
Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM) treatment 2 completed NCT00669669
O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas treatment 1 / 2 terminated NCT04772846
Chloroquine for Glioblastoma. treatment 1 / 2 unknown_status NCT02605746
Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis other 0 completed NCT05873946
Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery No drug interventions Not Available Not Available completed NCT00074646
Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas treatment 1 completed NCT04657146
Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma No drug interventions Not Available Not Available recruiting NCT04608812
Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection treatment 1 terminated NCT02253212
Safety of BBB Opening With the SonoCloud treatment 1 / 2 completed NCT03477110
Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma treatment 0 completed NCT01967810
ANG1005 in Patients With Recurrent High-Grade Glioma treatment 2 completed NCT02207010
A Phase 0 Study of AZD1775 in Recurrent GBM Patients other 0 completed NCT04443010
Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma treatment 1 / 2 recruiting NCT05927610
Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma No drug interventions diagnostic Not Available withdrawn NCT05974410
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients Not Available Not Available available NCT00870181
ADV-TK Improves Outcome of Recurrent High-Grade Glioma treatment 2 completed NCT06001281
Predictive Value of Soluble CD146 in Glioblastoma Patients No drug interventions basic_science Not Available recruiting NCT02329795
Image-derived Prediction of Response to Chemo-radiation in Glioblastoma Not Available Not Available terminated NCT05759195
Biomolecular Analysis for Predicting Response to Regorafenib No drug interventions other Not Available recruiting NCT03244995
Mind-Body Intervention in Glioma Couples No drug interventions supportive_care Not Available active_not_recruiting NCT03532295
Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas treatment 2 active_not_recruiting NCT03454295
Easing Psychosocial Burden for Informal Caregivers No drug interventions supportive_care 0 completed NCT05753995
Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study No drug interventions diagnostic Not Available recruiting NCT01564914
A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma treatment 2 completed NCT03075514
Ketogenic Diets as an Adjuvant Therapy in Glioblastoma No drug interventions treatment Not Available completed NCT02631655
POSitron Emission Imaging Using 18F-FDOPA in Neurooncology No drug interventions diagnostic Not Available completed NCT04547855
Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen treatment 2 unknown_status NCT05231655
Ex VIvo DEtermiNed Cancer Therapy No drug interventions Not Available Not Available recruiting NCT01310855
Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma treatment 2 terminated NCT02374255
Improving Goals of Care Discussion in Advanced Cancer Patients No drug interventions supportive_care Not Available completed NCT04863950
Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma treatment 2 recruiting NCT03344250
Phase I EGFR BATs in Newly Diagnosed Glioblastoma treatment 1 active_not_recruiting NCT01149850
Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma treatment 2 completed NCT03466450
Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma treatment 1 / 2 completed NCT03535350
Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma treatment 1 active_not_recruiting NCT04922723
Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma treatment 1 / 2 recruiting NCT02997423
Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM) No drug interventions Not Available Not Available completed NCT03661723
Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma treatment 2 active_not_recruiting NCT00613223
Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas treatment 1 completed NCT02458508
Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With Radiochemotherapy No drug interventions Not Available Not Available completed NCT00606008
A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma treatment 2 completed NCT00704808
Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739) Not Available Not Available completed NCT02799238
Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma treatment 2 completed NCT02092038
Preoperative Chemoradiation for Glioblastoma treatment 1 completed NCT06222138
Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma No drug interventions other Not Available recruiting NCT04116138
Antisecretory Factor in Primary Glioblastoma 1 No drug interventions treatment 1 / 2 completed NCT06132438
Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma No drug interventions treatment 1 not_yet_recruiting NCT02974738
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) treatment 1 active_not_recruiting NCT03868943
Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma supportive_care 2 suspended NCT05664243
A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma No drug interventions treatment 1 / 2 recruiting NCT02869243
A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients treatment 1 completed NCT05015543
Physical Training in Glioblastoma Patients During Cytotoxic Therapy No drug interventions supportive_care Not Available recruiting NCT03403803
Prognosis and Therapeutic Biomarkers for Glioblastoma Patients No drug interventions Not Available Not Available terminated NCT03149003
A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy treatment 3 completed NCT02157103
A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma treatment 2 completed NCT04047303
CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma treatment 1 terminated NCT00179803
Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors No drug interventions treatment 2 completed NCT02876003
Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma treatment 2 withdrawn NCT00961090
Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery treatment 2 completed NCT01861990
Valproic Acid in Childhood Progressive Brain Tumors treatment 1 withdrawn NCT01604590
Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme No drug interventions Not Available Not Available completed NCT01622764
89Zr-RO5323441 PET Imaging in Glioblastoma No drug interventions other 2 withdrawn NCT03119064
BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma treatment 1 / 2 terminated NCT00864864
Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma treatment 0 completed NCT01364064
Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma treatment 3 completed NCT04590664
Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma treatment 1 / 2 recruiting NCT03649464
Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants treatment 1 / 2 withdrawn NCT05186064
Glioblastoma Targeted Treatment Option Maximization by WGS No drug interventions diagnostic Not Available recruiting NCT02808364
Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2) No drug interventions treatment 1 completed NCT05781321
Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study treatment 2 recruiting NCT01872221
Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study No drug interventions other Not Available completed NCT05793021
FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype No drug interventions diagnostic Not Available recruiting NCT03258021
TTFields In GErmany in Routine Clinical Care No drug interventions Not Available Not Available unknown_status NCT01811121
MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS No drug interventions treatment 3 unknown_status NCT03020602
BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab treatment 1 completed NCT00597402
Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas treatment 2 completed NCT04181684
LITT Followed by Hypofractionated RT for Recurrent Gliomas No drug interventions treatment Not Available recruiting NCT04661384
Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma No drug interventions treatment 1 recruiting NCT03922984
Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma No drug interventions diagnostic Not Available recruiting NCT04315584
FDG and FDOPA PET Demonstration of Functional Brain Abnormalities No drug interventions diagnostic 0 unknown_status NCT01989884
An Efficacy Study Of Ortataxel In Recurrent Glioblastoma treatment 2 completed NCT01204684
Dendritic Cell Vaccine for Patients With Brain Tumors treatment 2 completed NCT01480479
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma treatment 3 completed NCT04028479
The Registry of Oncology Outcomes Associated With Testing and Treatment No drug interventions Not Available Not Available recruiting NCT04630379
Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers No drug interventions supportive_care Not Available completed NCT03395587
Efficiency of Vaccination With Lysate-loaded Dendritic Cells in Patients With Newly Diagnosed Glioblastoma treatment 2 recruiting NCT03749187
BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas treatment 1 recruiting NCT05938387
Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma No drug interventions treatment 1 recruiting NCT05835687
Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors No drug interventions treatment 1 recruiting NCT01985087
A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70 treatment 1 / 2 recruiting NCT05515133
Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients No drug interventions Not Available Not Available not_yet_recruiting NCT03739333
Early Diagnosis of Pseudoprogression Using 11C-Methionine PET-MRI After Concomitant Radiochemotherapy Treatment for Glioblastoma. No drug interventions diagnostic Not Available recruiting NCT04516733
Precoce Medical Care by the Mobil Support for Patients With Glioblastoma No drug interventions supportive_care Not Available completed NCT06388733
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma treatment 3 recruiting NCT04388033
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. treatment 1 / 2 unknown_status NCT03679754
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102 treatment 1 completed NCT05986851
Azeliragon in MGMT Unmethylated Glioblastoma treatment 2 active_not_recruiting NCT03243851
Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma treatment 2 completed NCT01430351
Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy treatment 1 active_not_recruiting NCT01499251
Clinical Study on the Safety and Tolerability of Macitentan in Combination With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma treatment 1 terminated NCT01637753
Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma treatment Not Available unknown_status NCT00385853
PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs treatment 1 completed NCT01579253
Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients No drug interventions Not Available Not Available unknown_status NCT04266977
Restrictive Use of Dexamethasone in Glioblastoma treatment Not Available recruiting NCT04681677
Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab treatment 2 terminated NCT05139277
Evaluation of the CONVIVO System No drug interventions diagnostic Not Available recruiting NCT03970447
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma treatment 2 / 3 recruiting NCT04802447
SurVaxM Expanded Access Protocol Not Available Not Available no_longer_available NCT02617745
Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid No drug interventions other 2 active_not_recruiting NCT01086345
Radiosurgery Plus Bevacizumab in Glioblastoma treatment 0 terminated NCT04747145
Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma treatment 2 recruiting NCT05686798
Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma. No drug interventions treatment 1 recruiting NCT03861598
Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells treatment 0 terminated NCT02861898
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma treatment 1 / 2 recruiting NCT02511405
A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE) treatment 3 completed NCT06147505
Natural Killer (NK) Cells (XS005) Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM) treatment 1 / 2 recruiting NCT02685605
Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme treatment 3 active_not_recruiting NCT05182905
AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients No drug interventions treatment 0 recruiting NCT03603405
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM treatment 1 / 2 recruiting NCT03174197
Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma treatment 1 / 2 active_not_recruiting NCT06490497
Expectations and Needs of a Glioblastoma Caregiver No drug interventions Not Available Not Available completed NCT00029783
Efficacy of Distant Healing in Glioblastoma Treatment No drug interventions treatment 2 completed NCT06183983
Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma No drug interventions diagnostic Not Available recruiting NCT00337883
A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme) treatment 2 completed NCT02133183
Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma treatment 1 terminated NCT04974983
Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent Glioblastoma No drug interventions Not Available Not Available completed NCT04270461
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors treatment 1 withdrawn NCT04221061
18F-FluorThanatrace (PET/CT) in Glioblastoma No drug interventions diagnostic 0 terminated NCT02465528
Ceritinib Rare Indications Study in ALK+ Tumors treatment 2 terminated NCT00613028
Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan treatment 2 completed NCT01498328
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma treatment 2 completed NCT05109728
A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent. treatment 1 recruiting NCT00611728
Ph I SU011248 + Irinotecan in Treatment of Pts w MG treatment 1 completed NCT02366728
DC Migration Study for Newly-Diagnosed GBM treatment 2 completed NCT06136611
Preoperative Preradiotherapy TTFields No drug interventions treatment Not Available not_yet_recruiting NCT06348693
Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness No drug interventions Not Available Not Available recruiting NCT05811793
Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma. treatment Not Available not_yet_recruiting NCT04826393
ASP8374 + Cemiplimab in Recurrent Glioma treatment 1 active_not_recruiting NCT03025893
A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme treatment 2 / 3 unknown_status NCT01867593
MET-PET for Newly Diagnosed Glioblastoma No drug interventions diagnostic 0 completed NCT00392171
The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601) treatment 2 completed NCT04708171
The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections No drug interventions Not Available Not Available recruiting NCT00001171
Evaluation of Factors in Human Brain Tumors No drug interventions Not Available Not Available completed NCT03919071
Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma treatment 2 recruiting NCT00610571
Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas treatment 1 completed NCT03776071
A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1 treatment 3 completed NCT03194971
NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy No drug interventions Not Available Not Available recruiting NCT01798771
Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery No drug interventions treatment Not Available unknown_status NCT02663271
TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma treatment 2 terminated NCT02039778
Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma No drug interventions treatment Not Available terminated NCT03383978
Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma treatment 1 active_not_recruiting NCT02327078
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) treatment 1 / 2 completed NCT04157478
Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma treatment 2 not_yet_recruiting NCT01441388
A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors. treatment 1 withdrawn NCT04822688
Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues No drug interventions Not Available Not Available recruiting NCT01765088
A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas treatment 3 unknown_status NCT03018288
Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM) treatment 2 terminated NCT01602588
A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG) treatment 2 completed NCT05753007
A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients treatment 2 recruiting NCT05798507
Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma treatment 0 recruiting NCT01392209
Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma No drug interventions treatment 1 completed NCT04629209
A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma treatment 2 withdrawn NCT01149109
Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients treatment 3 completed NCT04222309
Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM) No drug interventions treatment 1 suspended NCT02372409
Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors treatment 2 terminated NCT01208909
Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI) No drug interventions Not Available Not Available unknown_status NCT05990556
Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients No drug interventions treatment Not Available recruiting NCT00846456
Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma No drug interventions treatment 1 / 2 completed NCT05929456
Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid) diagnostic 1 recruiting NCT04074785
Abemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6 treatment 0 active_not_recruiting NCT04007185
Surgically Induced Neurological Deficits in Glioblastomas (SIND Study) No drug interventions Not Available Not Available active_not_recruiting NCT04566185
Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma No drug interventions Not Available Not Available unknown_status NCT03782415
Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma treatment 1 / 2 active_not_recruiting NCT03726515
CART-EGFRvIII + Pembrolizumab in GBM treatment 1 completed NCT04970615
Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models No drug interventions Not Available Not Available unknown_status NCT00576537
Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors treatment 2 completed NCT01174537
New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma No drug interventions treatment 1 / 2 withdrawn NCT00694837
Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma treatment 1 completed NCT04913337
Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies treatment 1 / 2 active_not_recruiting NCT04642937
Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma No drug interventions treatment 1 active_not_recruiting NCT03493932
Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade treatment 1 completed NCT03439332
Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma No drug interventions Not Available Not Available completed NCT00613132
Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG treatment 1 completed NCT04881032
AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma treatment 1 / 2 recruiting NCT01308632
Metronomic Temozolamide in Patients With Recurrent Glioblastoma treatment 2 / 3 unknown_status NCT00790452
Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma treatment 2 terminated NCT01849952
Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas No drug interventions Not Available Not Available recruiting NCT01339052
Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma treatment 2 completed NCT04856852
Iodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed Glioblastoma No drug interventions treatment Not Available unknown_status NCT01392352
HYPAZ: Hypertension Induced by Pazopanib basic_science 2 terminated NCT03393000
Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects treatment 3 terminated NCT05376800
A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma treatment 1 recruiting NCT05656300
Glioblastoma Imaging Using a Strong Iron-like Bloodpool Contrast Medium? No drug interventions Not Available Not Available not_yet_recruiting NCT04015700
Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma treatment 1 active_not_recruiting NCT05513859
Investigational Imaging Technique During Brain Surgery No drug interventions diagnostic Not Available not_yet_recruiting NCT03363659
Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme treatment 2 terminated NCT03975959
Memory Perception Assessment in Central/Non-central Nervous System Cancers No drug interventions supportive_care Not Available active_not_recruiting NCT00703859
Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma treatment 1 withdrawn NCT04825275
Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial treatment 0 recruiting NCT06140875
Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF) No drug interventions treatment Not Available recruiting NCT03149575
VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM treatment 3 terminated NCT01345370
Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients Not Available Not Available completed NCT02761070
Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III treatment 3 active_not_recruiting NCT01250470
Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma treatment 1 completed NCT02168270
Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma treatment 1 terminated NCT03717142
Feasibility of the LUM Imaging System for Detection of Cancer to the Brain No drug interventions other Not Available suspended NCT05541042
Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers No drug interventions Not Available Not Available not_yet_recruiting NCT03451799
Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma treatment 1 active_not_recruiting NCT02766699
A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent Glioblastoma Multiforme (GBM) No drug interventions treatment 1 unknown_status NCT03687099
Immunological and Functional Characterization of Cellular Population CD45+ Infiltrating Human Glioblastoma No drug interventions Not Available Not Available completed NCT00609999
Ph I Dasatinib + Erlotinib in Recurrent MG treatment 1 completed NCT06333899
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion treatment 0 not_yet_recruiting NCT05698199
Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM) No drug interventions treatment 1 active_not_recruiting NCT06108206
Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma No drug interventions treatment Not Available recruiting NCT03995706
Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0 treatment 0 completed NCT03956706
Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas No drug interventions treatment Not Available withdrawn NCT02769806
Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma No drug interventions Not Available Not Available terminated NCT02798406
Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects treatment 2 completed NCT05267106
Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations treatment 2 active_not_recruiting NCT04869449
Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas treatment 0 recruiting NCT03551249
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption No drug interventions treatment Not Available completed NCT01836549
Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors treatment 2 terminated NCT02728349
Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma treatment 1 completed NCT03643549
Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17) treatment 1 / 2 recruiting NCT04536649
Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma. No drug interventions treatment 3 not_yet_recruiting NCT03631836
Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma treatment 1 unknown_status NCT01043536
Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults treatment 1 completed NCT01836536
Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients basic_science Not Available completed NCT04118036
Abemaciclib + Pembrolizumab In Glioblastoma treatment 2 withdrawn NCT04752813
A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB) treatment 2 recruiting NCT04963413
RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients. No drug interventions treatment 1 terminated NCT05076513
Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma treatment 0 recruiting NCT03152318
A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 treatment 1 recruiting NCT05432518
Pilot Trial for Treatment of Recurrent Glioblastoma treatment 0 recruiting NCT03973918
Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG treatment 2 terminated NCT05768919
Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas No drug interventions treatment 1 / 2 recruiting NCT04006119
Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma treatment 2 completed NCT05476341
A Phase I Clinical Trial of Bevacizumab Injection treatment 1 completed NCT00884741
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma treatment 3 completed NCT02375841
Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers No drug interventions Not Available Not Available active_not_recruiting NCT04479241
LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma treatment 2 active_not_recruiting NCT00576641
Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma No drug interventions treatment 1 completed NCT02887417
Glioblastoma Platelet Activation Study No drug interventions Not Available Not Available completed NCT03347617
Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma treatment 2 active_not_recruiting NCT03687034
A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma treatment 1 unknown_status NCT01227434
A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma treatment 2 terminated NCT02315534
A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma treatment 1 / 2 completed NCT03714334
DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma No drug interventions treatment 1 terminated NCT03971734
Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas treatment 1 terminated NCT06368934
Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma No drug interventions treatment Not Available not_yet_recruiting NCT00190424
Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma No drug interventions treatment 2 completed NCT05698524
A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma treatment 1 recruiting NCT02573324
A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification treatment 3 completed NCT04606316
Surgical Nivolumab And Ipilimumab For Recurrent GBM treatment 1 active_not_recruiting NCT01331616
Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab treatment 0 withdrawn NCT03139916
Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma treatment 2 completed NCT02709616
Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC) No drug interventions treatment 1 completed NCT03626896
Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients No drug interventions device_feasibility Not Available completed NCT00028158
Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer No drug interventions treatment 1 / 2 completed NCT01740258
Bevacizumab Beyond Progression (BBP) treatment 2 completed NCT05653635
Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study No drug interventions treatment 2 not_yet_recruiting NCT04188535
Serial MRI Scans During Radiation Therapy No drug interventions other Not Available recruiting NCT04656535
AB154 Combined With AB122 for Recurrent Glioblastoma treatment 0 recruiting NCT03567135
Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma Not Available Not Available unknown_status NCT00009035
Natural History of Patients With Brain and Spinal Cord Tumors No drug interventions Not Available Not Available completed NCT05131763
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors treatment 1 unknown_status NCT06017063
Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields No drug interventions other Not Available not_yet_recruiting NCT02430363
Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475 treatment 1 / 2 unknown_status NCT00777686
Measuring Non-Enhancing Glioblastoma Progression No drug interventions Not Available Not Available completed NCT06492486
Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow No drug interventions treatment 2 not_yet_recruiting NCT04552886
Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma treatment 1 completed NCT03294486
Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients treatment 1 / 2 unknown_status NCT03475186
Testing Ramipril to Prevent Memory Loss in People With Glioblastoma supportive_care 2 active_not_recruiting NCT04902586
Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma No drug interventions treatment Not Available unknown_status NCT06448286
PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma treatment 3 not_yet_recruiting NCT04717739
TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study No drug interventions Not Available Not Available recruiting NCT01120639
Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform treatment 1 / 2 completed NCT05539339
Personalized Trial in ctDNA-level-relapse Glioblastoma No drug interventions treatment Not Available not_yet_recruiting NCT02844439
Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma treatment 2 completed NCT04910022
Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma treatment 1 / 2 recruiting NCT04933422
CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM) No drug interventions treatment 1 not_yet_recruiting NCT06146725
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202) No drug interventions Not Available Not Available recruiting NCT05728125
Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients No drug interventions Not Available Not Available not_yet_recruiting NCT03663725
Treatment Intensification With Temozolomide in Adults With a Glioblastoma No drug interventions treatment 3 recruiting NCT00686725
Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572) treatment 4 completed NCT04596930
MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma No drug interventions treatment Not Available completed NCT02843230
Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI No drug interventions Not Available Not Available completed NCT00612430
Ph II Bevacizumab + Etoposide for Pts w Recurrent MG treatment 2 completed NCT02630030
Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma basic_science 0 completed NCT03529448
TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma treatment 1 / 2 recruiting NCT02209948
Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma. treatment 2 completed NCT04678648
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies No drug interventions treatment 1 recruiting NCT01986348
Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas treatment 2 terminated NCT00001148
Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor No drug interventions Not Available Not Available completed NCT03008148
Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM treatment 2 / 3 recruiting NCT02455557
SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma treatment 2 active_not_recruiting NCT04205357
Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma treatment 1 completed NCT03707457
Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma treatment 1 terminated NCT04846257
Specific Preoperative Dynamic Contrast-enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of the Glioblastoma Tissue and Predict Recurrence No drug interventions Not Available Not Available completed NCT05970757
Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma No drug interventions diagnostic Not Available recruiting NCT00943826
A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma treatment 3 completed NCT04982926
A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer No drug interventions treatment 1 active_not_recruiting NCT05773326
Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG treatment 0 recruiting NCT00734526
Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma treatment 1 terminated NCT01082926
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 treatment 1 completed NCT04200066
A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma treatment 1 withdrawn NCT06176066
PH Sensitive MRI Based Resections of Glioblastoma No drug interventions treatment Not Available not_yet_recruiting NCT01242566
Temozolomide in Elderly Patients With KPS < 70 treatment 2 completed NCT04424966
Infigratinib in Recurrent High-Grade Glioma Patients treatment 0 terminated NCT00687765
Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma treatment 1 / 2 completed NCT02336165
Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma treatment 2 completed NCT01907165
Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide treatment 0 completed NCT01939574
A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma No drug interventions treatment Not Available unknown_status NCT03212274
Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations treatment 2 active_not_recruiting NCT01004874
Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma treatment 2 completed NCT01723020
A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma treatment 1 completed NCT05641220
Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study. No drug interventions Not Available Not Available not_yet_recruiting NCT05669820
Antisecretory Factor Glioblastoma Phase 2 No drug interventions treatment 2 / 3 recruiting NCT04541082
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms No drug interventions treatment 1 recruiting NCT02661282
Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma treatment 1 / 2 completed NCT05556382
Glioblastoma Evaluation for Heterogeneity In RadioseNsitivity No drug interventions Not Available Not Available recruiting NCT00521482
Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma treatment 2 unknown_status NCT02367482
Tryptophan Metabolism in Human Brain Tumors No drug interventions Not Available Not Available completed NCT00734682
A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas treatment 1 completed NCT03460782
An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas Not Available Not Available no_longer_available NCT05281731
Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma No drug interventions diagnostic Not Available recruiting NCT00977431
Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform treatment 1 completed NCT04763031
Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT No drug interventions treatment Not Available terminated NCT02669173
Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma treatment 1 active_not_recruiting NCT02575027
Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme No drug interventions treatment Not Available completed NCT05171127
Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument No drug interventions Not Available Not Available completed NCT00615927
Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG) treatment 2 completed NCT01922076
Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas treatment 1 completed NCT02227576
Prevention of Thrombocytopenia in Glioblastoma Patients treatment 2 terminated NCT06273176
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma No drug interventions Not Available Not Available recruiting NCT04691960
A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging treatment 2 recruiting NCT06552260
A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma treatment 0 not_yet_recruiting NCT06038760
Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO) No drug interventions Not Available Not Available recruiting NCT00941460
Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma treatment 2 completed NCT03355794
A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG) treatment 1 completed NCT02772094
Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas) No drug interventions treatment 2 unknown_status NCT05820191
B-amyloid as a Marker for GBM Bioimaging diagnostic 2 not_yet_recruiting NCT03043391
Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children treatment 1 completed NCT02750891
A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas No drug interventions treatment 1 / 2 completed NCT02337491
Pembrolizumab +/- Bevacizumab for Recurrent GBM treatment 2 completed NCT03426891
Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma treatment 1 completed NCT02330562
Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab treatment 1 / 2 completed NCT02977780
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) treatment 2 recruiting NCT03746080
Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma treatment 2 active_not_recruiting NCT04528680
Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma treatment 1 / 2 recruiting NCT04216329
Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma treatment 1 active_not_recruiting NCT03975829
Pediatric Long-Term Follow-up and Rollover Study treatment 4 recruiting NCT04610229
Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas. No drug interventions treatment Not Available completed NCT04814329
Glioblastoma Response Prediction to Apatinib No drug interventions Not Available Not Available completed NCT03630289
Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM No drug interventions treatment Not Available active_not_recruiting NCT00948389
Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM) treatment 1 / 2 terminated NCT00612989
Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM treatment 1 completed NCT05241392
Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma No drug interventions treatment 1 recruiting NCT00960492
Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma treatment 1 completed NCT04573192
A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression treatment 1 / 2 recruiting NCT02525692
Oral ONC201 in Recurrent GBM, H3 K27M Glioma, and Midline Glioma treatment 2 active_not_recruiting NCT05557292
RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma No drug interventions treatment 1 recruiting NCT01810744
Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma No drug interventions diagnostic Not Available completed NCT02014844
Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma treatment 2 completed NCT00115440
BNCT to Treat Glioma That Has Progressed Following Radiotherapy No drug interventions treatment 1 / 2 completed NCT02981940
A Study of Abemaciclib in Recurrent Glioblastoma treatment 2 active_not_recruiting NCT05772767
Modulation of Ciliogenesis in Glioma Stem Cells No drug interventions basic_science Not Available recruiting NCT03718767
Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype treatment 2 recruiting NCT05879367
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma treatment 1 recruiting NCT06279767
Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma treatment 1 / 2 recruiting NCT00657267
Dose-Intense Temozolomide in Recurrent Glioblastoma treatment 2 completed NCT02655601
Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001 treatment 2 active_not_recruiting NCT03231501
HMPL-813 in Treating Patients With Glioblastoma No drug interventions treatment 1 unknown_status NCT02910804
IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Glioblastoma No drug interventions diagnostic 0 unknown_status NCT05183204
Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma treatment 2 recruiting NCT03151772
Bioavailability of Disulfiram and Metformin in Glioblastomas other 0 terminated NCT02431572
A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy No drug interventions diagnostic Not Available completed NCT02529072
Nivolumab With DC Vaccines for Recurrent Brain Tumors treatment 1 completed NCT02062372
Spatial Analysis and Validation of Glioblastoma on 7 T MRI No drug interventions diagnostic Not Available terminated NCT04406272
VB-111 in Surgically Accessible Recurrent/Progressive GBM treatment 2 terminated NCT00397072
Epothilone in Recurrent Glioblastoma Patients treatment 2 completed NCT03388372
Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma treatment 2 completed NCT05538572
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors No drug interventions treatment 1 completed NCT02379572
Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas No drug interventions treatment Not Available completed NCT02465268
Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme treatment 2 completed NCT02864368
Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens treatment 1 terminated NCT05099068
Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET) No drug interventions diagnostic Not Available recruiting NCT01582269
A Study in Recurrent Glioblastoma (GB) treatment 2 active_not_recruiting NCT05660369
CARv3-TEAM-E T Cells in Glioblastoma No drug interventions treatment 1 recruiting NCT01700569
Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma treatment 1 terminated NCT05039346
Quality of Life and Patient Needs in Advanced High Grade Gliomas No drug interventions Not Available Not Available completed NCT04323046
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults treatment 1 recruiting NCT01849146
Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma treatment 1 active_not_recruiting NCT06297512
Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM). treatment 2 recruiting NCT00725010
Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816) Not Available Not Available completed NCT01225510
A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma treatment 2 withdrawn NCT02880410
Feasibility Study on LITT for Newly Diagnosed Glioblastoma treatment 1 terminated NCT01759810
Proteome-based Personalized Immunotherapy of Glioblastoma No drug interventions treatment 2 / 3 unknown_status NCT02658981
Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18) treatment 1 completed NCT04391595
LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients treatment 0 recruiting NCT05512195
Safety and Efficacy of a New Approach to Delineating Clinical Target Volume of Glioblastoma No drug interventions treatment Not Available not_yet_recruiting NCT00693095
Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer No drug interventions treatment 1 completed NCT02858895
Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma treatment 2 completed NCT04903795
Bispecific T Cell Engager BRiTE for Patients With Grade IV Malignant Glioma No drug interventions treatment 1 not_yet_recruiting NCT06041555
MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy) No drug interventions Not Available Not Available recruiting NCT00762255
A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma treatment 1 completed NCT04289155
Individual Patient Compassionate Use of GX-I7 No drug interventions Not Available Not Available no_longer_available NCT05700955
Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma treatment 1 recruiting NCT04121455
Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients treatment 1 / 2 active_not_recruiting NCT06118723
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) No drug interventions Not Available Not Available recruiting NCT05168423
CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM No drug interventions treatment 1 recruiting NCT05683808
Venous Thromboembolism Prevention in Outpatients With Glioma supportive_care 2 not_yet_recruiting NCT03055208
Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma No drug interventions treatment Not Available suspended NCT03152708
CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma No drug interventions Not Available Not Available unknown_status NCT01880008
Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma No drug interventions Not Available Not Available completed NCT05218408
CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type treatment 1 / 2 withdrawn NCT03587038
OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma treatment 1 active_not_recruiting NCT06146738
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203) No drug interventions Not Available Not Available recruiting NCT00171938
Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors) treatment 2 terminated NCT03115138
Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas. No drug interventions other Not Available terminated NCT06469138
A Phase 1 Study to Investigate 14C-bemcentinib Following Single Oral Administration in Healthy Male Subjects treatment 1 completed NCT01860638
A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma treatment 2 completed NCT01413438
Bevacizumab With or Without Surgery for Adult Glioblastomas No drug interventions treatment 2 withdrawn NCT00612638
Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas treatment 1 completed NCT02718443
VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma treatment 1 completed NCT03374943
A Trial of KB004 in Patients With Glioblastoma No drug interventions treatment 1 completed NCT00672243
Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme treatment 2 completed NCT02905643
Discerning Pseudoprogression vs True Tumor Growth in GBMs No drug interventions Not Available Not Available terminated NCT05173623
Trial of Dichloroacetate in Glioblastoma treatment 2 not_yet_recruiting NCT02661113
Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma: Phase II treatment 2 withdrawn NCT02671981
Concurrent Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma No drug interventions treatment 2 recruiting NCT03538587
Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers No drug interventions supportive_care Not Available completed NCT00936052
Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma No drug interventions treatment 2 unknown_status NCT03903419
Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients No drug interventions diagnostic Not Available unknown_status NCT01102595
Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma treatment 2 completed NCT01339039
Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma treatment 1 terminated NCT06617208
Prognostic IntraOperative Biomarkers IdeNtification in Tumor RElatEd SuRgery No drug interventions device_feasibility Not Available not_yet_recruiting NCT02046187
Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma treatment 1 / 2 terminated NCT03867123
A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients treatment 1 completed NCT05911230
Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases No drug interventions diagnostic Not Available recruiting NCT05431348
Effect of stRess and exeRcize on the Outcome After Chemo-Radiation No drug interventions Not Available Not Available recruiting NCT02758366
Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma treatment 2 terminated NCT02795364
Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas No drug interventions treatment Not Available unknown_status NCT01663012
Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma treatment 2 completed NCT00107003
GW572016 to Treat Recurrent Malignant Brain Tumors treatment 2 completed NCT05973903
Lenvatinib, Pembrolizumab, and Tumor Treating Fields (TTFields) for Second-line Treatment of Glioblastoma treatment 1 / 2 not_yet_recruiting NCT01856933
BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM) No drug interventions treatment 2 completed NCT05086497
WBSI Guided Personalized Delivery of TTFields No drug interventions diagnostic Not Available recruiting NCT04115761
Evaluate the Efficacy and Safety of ADCV01 as an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients No drug interventions treatment 2 unknown_status NCT03746288
To Evaluate the Efficacy and Safety of CAN008 Combined With Re-irradiation (rRT) for Treating Patients With Recurrent Glioblastoma (GBM) treatment 2 unknown_status NCT06039709
Sonodynamic Therapy in Patients With Recurrent GBM treatment 1 recruiting NCT03367715
Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma treatment 2 completed NCT01238237
Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA treatment 1 completed NCT03005132
Integrative Analysis of Human Glioblastoma Multiforme No drug interventions Not Available Not Available recruiting NCT01756352
FET-PET for Evaluation of Response of Recurrent GBM to Avastin diagnostic 2 completed NCT01205334
Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme No drug interventions treatment 1 / 2 terminated NCT00591058
Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma treatment 1 unknown_status NCT01124539
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma treatment 2 unknown_status NCT02623231
The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients supportive_care 2 / 3 unknown_status NCT06396481
Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma No drug interventions treatment 0 not_yet_recruiting NCT03758014
Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients treatment 2 / 3 unknown_status NCT06092255
A Study of SVZ Irradiation With Postoperative Radiotherapy in Patients With GBM. No drug interventions treatment Not Available recruiting NCT00683761
A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma No drug interventions treatment 1 / 2 unknown_status NCT06538428
Methylation Patterns of the NUPR1, MGMT, NDRG2, and GLI1 Genes and Their Impact on Therapeutic Outcome of GBM Patients No drug interventions Not Available Not Available completed NCT00114309
131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma treatment 2 unknown_status NCT06439849
Single Patient Compassionate Use / Expanded Access L-S-Gboxin (Lyophilized Form of S-Gboxin) for the Treatment of Diffuse Midline Glioma Not Available Not Available no_longer_available NCT02146066
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221 Not Available Not Available available